Written by K Krumwiede, Markus Horneber and the CAM-Cancer Consortium.
Updated February 8, 2017

Breuss Cancer Cure

Abstract and key points

  • The Breuss Cancer Cure includes a 42-day fast in combination with special vegetable juices and teas.
  • There is not sufficient evidence to support the Breuss Cancer Cure as a cancer treatment.
  • The fast could cause malnutrition and patients are advised to discontinue conventional cancer treatment.

The core of the Breuss Cancer Cure is a rigid diet, which consists of a 42-day fast in combination with special vegetable juices and teas. Additional recommendations are included, for instance, to avoid so-called water veins. According to Breuss’s theory, cancer requires solid food to survive in the body.

The claims of efficacy are not supported by sufficient evidence and there are no reliable scientific data to support the claimed mode of action.

It is likely that the recommended fast could be dangerous for cancer patients because there is a potential risk of general malnutrition. As Breuss bans conventional cancer treatment while patients undergo his treatment, there is a risk that patients will discontinue conventional treatment.

Scientific examinations of the benefits and dangers of Breuss Cancer Cure are lacking.

Citation

K Krumwiede, Markus Horneber , CAM-Cancer Consortium. Breuss Cancer Cure [online document]. http://www.cam-cancer.org/The-Summaries/Dietary-approaches/Breuss-Cancer-Cure. February 8, 2017.

Document history

Assessed as up to date in February 2017 by Barbara Wider
Assessed as up to date in January 2016 by Barbara Wider.
Assessed as up to date in January 2015 by Barbara Wider.
Assessed as up to date in August 2013 by Barbara Wider.
Last updated in by March 2012 by Karl Krumwiede.
Updated and revised in January 2011 by Karl Krumwiede.
Fully updated and revised in October 2009 by Karl Krumwiede and Markus Horneber.
Summary first published in November 2005, authored by Karl Krumwiede and Markus Horneber.

References

  1. Breuss R. Krebs - Leukämie und andere scheinbar unheilbare Krankheiten mit natürlichen Mitteln heilbar. Mebus; 1990.
  2. Breuss R. The Breuss Cancer Cure. Alive books Canada; 1995.
  3. Moerman C, Breuss R. Krebs - Leukämie und andere scheinbar unheilbare Krankheiten - mit natürlichen Mitteln heilen. 12 ed. Freiburg i. Br.: Aurum in J. Kamphausen Verlag; 2004.
  4. Merk J. Wangen im Allgäu. 2005.
  5. Thomar, J. H. R. Die Krebskur total nach Rudolph Breuss richtig gemacht. 2008. Eigenverlag J.H.R. Thomar Pullendorf.
  6. Mit der Breuss Kur...., http://www.breuss-kur.de, (accessed on 8 February 2017).
  7. Krebsheilung mit der Breusskur. http://www.krebscafe.de/blog/2008/09/10/krebsheilung-mit-der-breuss-kur/ (accessed on 8 February 2017).
  8. Kroiss-Cancer-Center, http://www.dr-kroiss.at/krankheiten/krebs.html, (accessed on 8 February 2017).
  9. ...den Krebs in 42 Tagen weghungern, http://www.krebs-gesundfasten.de/ (accessed on 8 February 2017).
  10. https://fasten-zentrum.de/breussfasten/, (accessed on 8 February 2017).
  11. http://www.stilles-haus.de/gesundheitsurlaub/fasten-heilfasten/fasten-nach-breuss.html (accessed on 8 February 2017).
  12. Biotta AG, http://www.biotta.ch/en/products/classic/breuss, (accessed on 8 February 2017).
  13. Douwes FR, et al. Hat das Fasten in der Therapie von Tumorpatienten einen Sinn? Teil 2. Krebsgeschehen 1984;6:141-9.
  14. Jungi WF. Diättherapie maligner Tumoren. In: Oepen I editor. An den Grenzen der Schulmedizin. Köln: Deutscher Ärzte Verlag; 1985p. 123-42.
  15. Pfortmüller, J. Breuss´sche Saftkur gegen Krebs. Neue Luzerner Zeitung , 1. 2003.
  16. Berrigan D, Perkins SN, Haines DC, Hursting SD. Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 2002;23(5):817-22.
  17. Leary MP, Jacobson MK, Phillips FC, Getzin SC, Grande JP, Maihle NJ. Weight-cycling decreases incidence and increases latency of mammary tumors to a greater extent than does chronic caloric restriction in mouse mammary tumor virus-transforming growth factor-alpha female mice. Cancer Epidemiol Biomarkers Prev 2002;11(9):836-43.
  18. Ruggeri BA, Klurfeld DM, Kritchevsky D, Furlanetto RW. Caloric restriction and 7,12-dimethylbenz(a)anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Research 1989;49:4130-4134.
  19. Thompson HJ, Zhu Z, Jiang W. Protection against cancer by energy restriction: all experimental approaches are not equal. J Nutr 2002;132:1047-1049.
  20. Cleary MP, Hu x, Grossmann ME, Juneja SC, Dogan S, Grande JP, Maihle NJ. Prevention of mammary tumorgenesis by intermittent caloric restriction: does caloric intake during refeeding modulate the response? Exp Biol Med 2007;232(1):70-80.
  21. Pugh TD, Oberley Td, Weindruch R. Dietary intervention at middle age: caloric restriction but not dehydroepiandrosterone sulphate icreases lifespan and lifetime cancer incidence in mice. Cancer Research 1999;59:1642-1648.
  22. Mai V, Colbert LH, Berrigan D, Perkins SN, Pfeiffer R, Lavigne JAet al. Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms. Cancer Res 2003;63(8):1752-5.
  23. Zhu Z, Haegele AD, Thompson HJ. Effect of caloric restriction on pre-malignant and malignant stages of mammary carcinogenesis. Carcinogenesis 1997;18(5):1007-1012.
  24. Weindruch R, Wlford RL. Dietary restriction in mice beginning at 1 year of age: effect on lifespan and spontaneous cancer incidence. Science 1982;215(4538):1415-1418.
  25. Kritchevsky D. Caloric restriction and cancer. J Nutr Sci Vitaminol 2001;47(1):13-19.
  26. Kritchevsky D. Caloric restriction and experimental carcinogenesis. Hybrid Hybridomics 2002;2:147-151.
  27. Tannenbaum A, Silverstone H. Nutrition in relation to cancer. Adv Cancer Res 1953;1:451-501.
  28. Cheney KE, Liu RK, Smith GS, Leung RE, Mickey MR, Walford RL. Survival and disease patterns in C57BL/6J mice subjectes to undernutrition. Exp Gerontol 1980;15(4):237-258.
  29. Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC. Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 2003;54:131-152.
  30. Kalaany NY, Sabatini DM. Tumours with PI3K activation are resistant to dietary restriction. Nature 2009;458(7239):725-731.
  31. Tomasi C, Laconi E, Laconi S, Greco M, Sarma DS, Pani P. Effect of fasting/refeeding on the incidence of chemically induced hepatocellular carcinoma in the rat. Carcinogenesis 1999;20(10):1979-83.
  32. Goodgame JT, Jr., Lowry SF, Reilly JJ, Jones DC, Brennan MF. Nutritional manipulations and tumor growth. I. The effects of starvation. Am J Clin Nutr 1979;32(11):2277-84.
  33. Goodstein ML, Richtsmeier WJ, Sauer LA. The effect of an acute fast on human head and neck carcinoma xenograft. Growth effects on an 'isolated tumor vascular pedicle' in the nude rat. Arch Otolaryngol Head Neck Surg 1993;119(8):897-902.
  34. Hikita H, Vaughan J, Babcock K, Pitot HC. Short-term fasting and the reversal of the stage of promotion in rat hepatocarcinogenesis: role of cell replication, apoptosis, and gene expression. Toxicol Sci 1999;52(2 Suppl):17-23.
  35. Hikita H, Vaughan J, Pitot HC. The effect of two periods of short-term fasting during the promotion stage of hepatocarcinogenesis in rats: the role of apoptosis and cell proliferation. Carcinogenesis 1997;18(1):159-66.
  36. Premoselli F, Sesca E, Chiara M, Binasco V, Tessitore L. Fasting/refeeding enhances the crypt multiplicity in rat colon carcinogenesis induced by azoxymethane. Boll Soc Ital Biol Sper 1996;72(9-10):239-45.
  37. Sauer LA, Nagel WO, Dauchy RT, Miceli LA, Austin JE. Stimulation of Tumor Growth in Adult Rats in Vivo during an Acute Fast. Cancer Res 1986;46:3469-75.
  38. Sauer LA, Dauchy RT. Blood nutrient concentrations and tumor growth in vivo in rats: relationships during the onset of an acute fast. Cancer Research 1987;47:1065-1068.
  39. Torosian MH, Daly JM. Nutritional support in the cancer-bearing host. Cancer 1986;58:1915-1929.
  40. Laconi E, Tessitore L, Milia G, Yusuf A, Sarma DS, Todde P, Pani P. The enhancing effect of fasting/refeeding on the growth of nodules selectable by the resistant hepatocyte model in rat liver. Carcinogenesis 1995;16:1865-1869.
  41. Tessitore L, Tomasi C, Greco M, Sesca E, Laconi E, Maccioni O, Ramo R, Pani P. A subnecrogenic dose of diethylnitrosamine is able to inhibite hepatocarcinogenensis in the rat when coupled with fasting/refeeding. Carcinogenesis 1996;17:289-292.
  42. Senn HJ, Jungi WF. Krebskur total. Schweiz Ärztezeitung 1979;34:1678-80.
  43. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 2002;52(2):72-91.
  44. Zürcher G. Medikamentöse Strategien zur Gewichtszunahme bei kachektischen Patienten. Akt Ernähr Med 2002;27:398-407.
  45. Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller Set al. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 2005;23(25):6240-8.
  46. Krebskur total nach Breuss. Dokumentation Nr. 2. Schweiz Rundsch Med 1987;76:1165-6.
  47. Schweizer Krebsliga. Krebskur-total nach Breuss. Dokumentation Schweiz Gesellschaft [2 D]. 1982. Bern, Schweizerische Krebsliga.